01.06.26 -- Hidden Sensitive Data Liability: Why Legacy Web Forms Put Life Sciences Organizations At Critical Risk

Explore how certain drivers are impacting traditional drug development strategies and relationships with outsourced drug development and manufacturing partners.

Learn about FDA regulation 21 CFR Part 11 and the critical role it plays in ensuring pharmaceutical and medical product manufacturers properly manage and track their data.

In this presentation, Dr. Nigel Jackson, Principal Engineer in R&D, offers an in-depth discussion on regulatory guidance and recent updates pertaining to virus filtration.

Many growing industries face universal tablet compression challenges, demanding better tooling, tighter process control, and more integrated data to ensure product consistency and reliable scale-up.

Discover the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.

See how applying lyophilization-based micronization methodology at a small scale helps to support challenging formulation development projects.

Combining Functional Design of Experiments (DOE) with traditional DOE methods enhances process optimization by capturing dynamic, time-based variations in cell culture systems.

Gain insight into how automated z-stack imaging and AI-based analysis enable accurate, label-free monitoring of spheroid development in 3D matrices for drug screening and cell culture workflows.

Transforming the pharma workforce requires strategic partnerships and a shift toward behavioral and operational readiness, moving beyond simple technical training to ensure performance and compliance.

Product recalls impact revenue and reputation. Implementing inspection systems like X-ray, vision inspection, and metal detection helps prevent contamination and regulatory issues.